A Randomized Phase II Trial of Fludarabine/Melphalan 100 versus Fludarabine/Melphalan 140 Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Multiple Myeloma-Reference-Cited by-同舟云学术

A Randomized Phase II Trial of Fludarabine/Melphalan 100 versus Fludarabine/Melphalan 140 Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Multiple Myeloma

Published:2013-10 Issue:10 Volume:19 Page:1453-1458
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Bashir Qaiser,Khan Hassan,Thall Peter F.,Liu Ping,Shah Nina,Kebriaei Partow,Parmar Simrit,Oran Betul,Ciurea Stefan,Nieto Yago,Jones Roy,Hosing Chitra M.,Popat Uday R.,Dinh Yvonne T.,Rondon Gabriela,Orlowski Robert Z.,Shah Jatin J.,De Lima Marcos,Shpall Elizabeth,Champlin Richard,Giralt Sergio,Qazilbash Muzaffar H.

Funder

University of Texas M.D. Anderson Cancer Center

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference56 articles.

1. Is there still a role for allogeneic stem-cell transplantation in multiple myeloma?;Bensinger;Best Pract Res Clin Haematol,2007

2. Allogeneic transplantation for multiple myeloma: Further evidence for a GVHD-associated graft-versus-myeloma effect;Le Blanc;Bone Marrow Transplant,2001

3. Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: Final results of phase III US Intergroup Trial S9321;Barlogie;J Clin Oncol,2006

4. Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma;Gahrton;Haematologica,2007

5. Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma;Kroger;Blood,2002

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Melphalan Dose in Combination With Fludarabine Affects Gastrointestinal Toxicity and Graft-Versus-Host Disease After Allogeneic Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndromes;Transplantation and Cellular Therapy;2024-08

2. Efficacy and survival outcome of allogeneic stem-cell transplantation in multiple myeloma: meta-analysis in the recent 10 years;Frontiers in Oncology;2024-07-31

3. Nation-Wide Retrospective Analysis of Allogeneic Stem Cell Transplantation in Patients with Multiple Myeloma: A Study from Korean Multiple Myeloma Working Party (KMM1913);Cancer Research and Treatment;2024-07-15

4. Preparative Regimens Used in Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapies;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

5. Improved survival after single-unit cord blood transplantation using fludarabine and melphalan-based reduced-intensity conditioning for malignant lymphoma: impact of melphalan dose and graft-versus-host disease prophylaxis with mycophenolate mofetil;Annals of Hematology;2022-10-05